Thailand’s Chulalongkorn University is expected to transfer technology for the mass production of its vaccine, ChulaCov 19 mRNA, to a local manufacturer in the first quarter of next year, according to Professor Dr. Kiat Ruxrungtham, director of the vaccine’s development project.

 

Speaking at a panel discussion on the progress of research and development of the vaccine, at the 5th Chula The Impact event on Thursday, Dr. Kiat said that the centre started the first stage of human clinical trials of the candidate vaccine on June 14th, involving 36 volunteers in the 18-55 age group and 36 volunteers aged 56-75. The two groups of volunteers were given two doses of vaccine three weeks apart.

 

Initial trial results show no serious side effects in the volunteers of the 18-55 age group, with mild and moderate side effects which improve in 1-2 days, said Dr. Kiat, adding that consultations are under way with the Thai Food and Drug Administration (TFDA) for the launch of the second phase of human clinical trials.

 

Discover Cigna’s range of health insurance solutions created for expats and local nationals living in Thailand - click to view

 

Full story: https://www.thaipbsworld.com/mass-production-of-thailands-chulacov-19-mrna-vaccine-expected-early-next-year/

 

-- © Copyright Thai PBS 2021-11-19

 

- Whatever you're going through, the Samaritans are here for you

- Follow ASEAN NOW on LINE for breaking COVID-19 updates

Be a good assist if vaccination become an annual requirement 

The tablet form may however come into play also

 

24 minutes ago, webfact said:

Thailand’s Chulalongkorn University is expected to transfer technology for the mass production of its vaccine, ChulaCov 19 mRNA, to a local manufacturer in the first quarter of next year

Should they not complete clinical trials and possibly peer reviews prior to issuing these kind of statements .....????????

21 minutes ago, Geoffggi said:

Should they not complete clinical trials and possibly peer reviews prior to issuing these kind of statements .....????????

No this is Thailand they do what they want as evidenced by using the Fa Talai Jones and Favipiravir.

26 minutes ago, Geoffggi said:

Should they not complete clinical trials and possibly peer reviews prior to issuing these kind of statements .....????????

Nah...likely safer than your local SomTam stall

6 hours ago, webfact said:

Thailand’s Chulalongkorn University is expected to transfer technology for the mass production of its vaccine, ChulaCov 19 mRNA, to a local manufacturer in the first quarter of next year,

Maybe in time for boosters.

I can’t see this getting WHO approval based on the extent of the trials referenced in the article. And no WHO approval means not accepted by other countries. So presumably this is for those who have no intention to travel and are sufficiently uneducated to take a vaccine on trust rather than scientific evidence.

 

personally I’ll give it pass, but my wife is turning down every other vaccine while she waits for this one. Based on……nationalistic fervor?

31 minutes ago, hotchilli said:

Maybe in time for boosters.

My bone density has not deteriorated enough yet to need to use a booster in my car to drive, not yet at least....oh wait wrong booster....

One can't deny the name is intimidating. Regardless of what it contains, the marketing is done.

13 hours ago, ThailandRyan said:

My bone density has not deteriorated enough yet to need to use a booster in my car to drive, not yet at least....oh wait wrong booster....

Booster TR not warp drive.

22 hours ago, Geoffggi said:

Should they not complete clinical trials and possibly peer reviews prior to issuing these kind of statements .....????????

Why start now?